Cytiva, formerly part of GE Healthcare Life Sciences, has launched the first liquid nitrogen-free cryogenic shipment system designed and optimised for the shipment of cellular therapies and cryopreserved apheresis.
The VIA Capsule system comprises a shipper unit, an integrated smart monitor, and a cryocooler. Combined, these provide the conditions and functionality required to ensure cell viability during the entire logistics process from the manufacturer to the patient’s bedside.
Catarina Flyborg, Vice-President of Cytiva Cell and Gene Therapy, said, “Ensuring that cryogenic temperature is maintained from the bench to the bedside is paramount for cellular therapies.”
“The VIA Capsule system reduces many risks, as well as the complexities and inefficiencies, associated with the current shipping methods, to ensure the safe delivery of life-saving therapies.”
... to continue reading you must be subscribed
